Orion Market Research
India Generic Drugs Market, Size, Share, Analysis Report
& Forecast to 2026
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404
India generic drugs market is estimated to grow at a CAGR of nearly 9.5% during the forecast period.
A significant rise in the incidences of chronic diseases is driving the demand for generic drugs in the
country. The National Cancer Registry Programme estimates that there will be 13.9 lakh new cancer
incidences reported in India in 2020, which is expected to rise to 15.7 lakh by 2025. This leads to increasing
demand for generic drugs that are playing a crucial role in cancer treatment. For instance, in everyday
practice, patients with early-stage breast cancer, and children suffering from acute lymphoblastic
leukemia are treated and cured with generics. In cancer care, generic drugs are also significantly used in
supportive care beyond chemotherapy.
(Get 15% Discount on Buying this Report)
A full Report of India Generic Drugs Market is Available at: https://www.omrglobal.com/industry-
The increasing prevalence of diabetes is also supporting to drive market growth. As per the International
Diabetes Federation (IDF), the total cases of diabetes reported in adults in India was nearly 77 million in
2019. This leads to increasing demand for generic medicines for diabetes which include Tolazamide
(Tolinase), Acetohexamide, and Glimepiride (Amaryl). Additionally, several generic equivalents of the drug
metformin (earlier sold only as Glucophage XR or Glucophage) are now available.
Scope of the India Generic Drugs Market